Kroenke K, Spitzer RL, Williams JB, Linzer M, Hahn SR, deGruy FV III, Brody D. 1994. Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch Fam Med 3(9):774–779.

Link BG, Phelan JC, Bresnahan M, Stueve A, Pescosolido BA. 1999. Public conceptions of mental illness: Labels, causes, dangerousness, and social distance. Am J Public Health 89(9):1328–1333.

Marbach JJ, Lennon MC, Link BG, Dohrenwend BP. 1990. Losing face: Sources of stigma as perceived by chronic facial pain patients. J Behav Med 13(6):583–604.

Miller CS, Prihoda TJ. 1999. A controlled comparison of symptoms and chemical intolerances reported by Gulf War veterans, implant recipients and persons with multiple chemical sensitivity. Toxicol Ind Health 15(3–4):386–397.

Murphy FM, Kang H, Dalager NA, Lee KY, Allen RE, Mather SH, Kizer KW. 1999. The health status of Gulf War veterans: Lessons learned from the Department of Veterans Affairs Health Registry. Mil Med 164(5):327–331.

Nethercott JR, Davidoff LL, Curbow B, Abbey H. 1993. Multiple chemical sensitivities syndrome: Toward a working case definition. Arch Environ Health 48(1):19–26.

Penn DL, Martin J. 1998. The stigma of severe mental illness: Some potential solutions for a recalcitrant problem. Psychiatr Q 69(3):235–247.

Pollet C, Natelson BH, Lange G, Tiersky L, DeLuca J, Policastro T, Desai P, Ottenweller JE, Korn L, Fiedler N, Kipen H. 1998. Medical evaluation of Persian Gulf veterans with fatigue and/or chemical sensitivity. J Med 29(3/4):101–113.

Reid S. 1999. Multiple chemical sensitivity—Is the environment really to blame? J R Soc Med 92(12):616–619.

Research Working Group of the Persian Gulf Veterans Coordinating Group. 1999. Annual Report to Congress: Federally Sponsored Research on Gulf War Veterans’ Illnesses for 1998. Washington, DC: Department of Veterans Affairs.

Robbins JM, Kirmayer LJ, Hemami H. 1997. Latent variable models of functional somatic distress. J Nerv Ment Dis 185(10):606–615.

Robins E, Guze SB. 1970. Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia. Am J Psychiatry 126(7):983–987.

Rosenberg CE. 1988. Disease and social order in America: Perceptions and expectations. In: Fee E, Fox DM, eds. AIDS: The Burden of History. Berkeley: University of California Press. Pp. 12–33.

Russell IJ. 1998. Advances in fibromyalgia: Possible role for central neurochemicals. Am J Med Sci 315(6):377–384.

Scadding JG. 1996. Essentialism and nominalism in medicine: Logic of diagnosis in disease terminology. Lancet 348(9027):594–596.

Sharpe M. 1998. Doctors’ diagnoses and patients’ perceptions. Lessons from chronic fatigue syndrome. Gen Hosp Psychiatry 20(6):335–338.

Sharpe M, Hawton K, Simkin S, Surawy C, Hackmann A, Klimes I, Peto T, Warrell D, Seagroatt V. 1996. Cognitive behaviour therapy for the chronic fatigue syndrome: A randomized controlled trial. BMJ 312(7022):22–26.

Simon GE, Daniell W, Stockbridge H, Claypoole K, Rosenstock L. 1993. Immunologic, psychological, and neuropsychological factors in multiple chemical sensitivity. A controlled study. Ann Intern Med 119(2):97–103.

Slotkoff AT, Radulovic DA, Clauw DJ. 1997. The relationship between fibromyalgia and the multiple chemical sensitivity syndrome. Scand J Rheumatol 1997 26(5):364–367.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement